MYT NETHERLANDS PARENT BV (MYTE)
US55406W1036 - ADR
Taking everything into account, MYTE scores 4 out of 10 in our fundamental rating. MYTE was compared to 120 industry peers in the Specialty Retail industry. While MYTE seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, MYTE is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year MYTE was profitable.
In the past year MYTE had a positive cash flow from operations.
In the past 5 years MYTE reported 4 times negative net income.
In multiple years MYTE reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.41%, MYTE is doing worse than 68.64% of the companies in the same industry.
MYTE has a Return On Equity (-8.76%) which is in line with its industry peers.
MYTE has a worse Return On Invested Capital (0.40%) than 63.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.41% | ||
| ROE | -8.76% | ||
| ROIC | 0.4% |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of MYTE (0.29%) is worse than 63.56% of its industry peers.
MYTE's Gross Margin of 46.77% is fine compared to the rest of the industry. MYTE outperforms 72.88% of its industry peers.
In the last couple of years the Gross Margin of MYTE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.29% | ||
| PM (TTM) | N/A | ||
| GM | 46.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MYTE is destroying value.
Compared to 1 year ago, MYTE has more shares outstanding
Compared to 5 years ago, MYTE has less shares outstanding
MYTE has a better debt/assets ratio than last year.
2.2 Solvency
MYTE has an Altman-Z score of 3.92. This indicates that MYTE is financially healthy and has little risk of bankruptcy at the moment.
MYTE's Altman-Z score of 3.92 is amongst the best of the industry. MYTE outperforms 82.20% of its industry peers.
The Debt to FCF ratio of MYTE is 11.15, which is on the high side as it means it would take MYTE, 11.15 years of fcf income to pay off all of its debts.
MYTE has a Debt to FCF ratio (11.15) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.16 indicates that MYTE is not too dependend on debt financing.
MYTE's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. MYTE outperforms 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 11.15 | ||
| Altman-Z | 3.92 |
ROIC/WACC0.06
WACC7.02%
2.3 Liquidity
A Current Ratio of 1.95 indicates that MYTE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.95, MYTE is in the better half of the industry, outperforming 78.81% of the companies in the same industry.
MYTE has a Quick Ratio of 1.95. This is a bad value and indicates that MYTE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.26, MYTE is doing worse than 79.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.95 | ||
| Quick Ratio | 0.26 |
3. Growth
3.1 Past
MYTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.67%, which is quite impressive.
The Revenue has grown by 9.51% in the past year. This is quite good.
MYTE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.27% yearly.
EPS 1Y (TTM)41.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)9.51%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%7.41%
3.2 Future
The Earnings Per Share is expected to grow by 54.63% on average over the next years. This is a very strong growth
MYTE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.58% yearly.
EPS Next Y227.25%
EPS Next 2Y98.81%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year8.01%
Revenue Next 2Y8.86%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.22 indicates a quite expensive valuation of MYTE.
The rest of the industry has a similar Price/Earnings ratio as MYTE.
The average S&P500 Price/Earnings ratio is at 27.41. MYTE is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 22.18, which indicates a rather expensive current valuation of MYTE.
MYTE's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.69. MYTE is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.22 | ||
| Fwd PE | 22.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MYTE indicates a slightly more expensive valuation: MYTE is more expensive than 64.41% of the companies listed in the same industry.
MYTE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.16 | ||
| EV/EBITDA | 30.66 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYTE's earnings are expected to grow with 54.63% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y98.81%
EPS Next 3Y54.63%
5. Dividend
5.1 Amount
No dividends for MYTE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MYT NETHERLANDS PARENT BV
NYSE:MYTE (1/3/2025, 8:04:01 PM)
7.24
-0.24 (-3.21%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners17.99%
Inst Owner Change-28.37%
Ins Owners1.44%
Ins Owner ChangeN/A
Market Cap614.61M
Analysts74.55
Price Target6.55 (-9.53%)
Short Float %0.69%
Short Ratio0.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)77.99%
Min EPS beat(2)-50.98%
Max EPS beat(2)206.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)-3.03%
Revenue beat(4)0
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)-0.69%
Revenue beat(8)2
Avg Revenue beat(8)-1.82%
Revenue beat(12)3
Avg Revenue beat(12)-2%
Revenue beat(16)6
Avg Revenue beat(16)-0.85%
PT rev (1m)20.68%
PT rev (3m)38.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29.63%
EPS NY rev (1m)19.38%
EPS NY rev (3m)-23.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.77%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.22 | ||
| Fwd PE | 22.18 | ||
| P/S | 0.7 | ||
| P/FCF | 89.16 | ||
| P/OCF | 35.71 | ||
| P/B | 1.43 | ||
| P/tB | 2.27 | ||
| EV/EBITDA | 30.66 |
EPS(TTM)0.18
EY2.49%
EPS(NY)0.33
Fwd EY4.51%
FCF(TTM)0.08
FCFY1.12%
OCF(TTM)0.2
OCFY2.8%
SpS10.39
BVpS5.07
TBVpS3.19
PEG (NY)0.18
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.41% | ||
| ROE | -8.76% | ||
| ROCE | 0.53% | ||
| ROIC | 0.4% | ||
| ROICexc | 0.4% | ||
| ROICexgc | 0.6% | ||
| OM | 0.29% | ||
| PM (TTM) | N/A | ||
| GM | 46.77% | ||
| FCFM | 0.78% |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score4
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 11.15 | ||
| Debt/EBITDA | 3.06 | ||
| Cap/Depr | 52.8% | ||
| Cap/Sales | 1.17% | ||
| Interest Coverage | 0.44 | ||
| Cash Conversion | 78.01% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.95 | ||
| Quick Ratio | 0.26 | ||
| Altman-Z | 3.92 |
F-Score4
WACC7.02%
ROIC/WACC0.06
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y227.25%
EPS Next 2Y98.81%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)9.51%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%7.41%
Revenue Next Year8.01%
Revenue Next 2Y8.86%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y120.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.61%
EBIT Next 3Y75.82%
EBIT Next 5YN/A
FCF growth 1Y-83.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.2%
OCF growth 3YN/A
OCF growth 5Y33.41%